Cargando…

A Novel Technique for Repositioning of a Migrated ILUVIEN(®) (Fluocinolone Acetonide) Implant into the Anterior Chamber

INTRODUCTION: Fluocinolone acetonide (FAc) intravitreal implant (ILUVIEN(®); Alimera Sciences Limited, Aldershot, UK) has been approved in the UK for the treatment of chronic diabetic macula edema, insufficiently responsive to available therapies. It is inserted into the vitreous cavity through a 25...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Ghrably, Ibraheem A., Saad, Ahmed, Dinah, Christiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675734/
https://www.ncbi.nlm.nih.gov/pubmed/26199036
http://dx.doi.org/10.1007/s40123-015-0035-1
_version_ 1782405050944978944
author El-Ghrably, Ibraheem A.
Saad, Ahmed
Dinah, Christiana
author_facet El-Ghrably, Ibraheem A.
Saad, Ahmed
Dinah, Christiana
author_sort El-Ghrably, Ibraheem A.
collection PubMed
description INTRODUCTION: Fluocinolone acetonide (FAc) intravitreal implant (ILUVIEN(®); Alimera Sciences Limited, Aldershot, UK) has been approved in the UK for the treatment of chronic diabetic macula edema, insufficiently responsive to available therapies. It is inserted into the vitreous cavity through a 25-gauge needle. Migration of the implant to the anterior chamber (AC) can occur through gaps in the posterior capsule especially in vitrectomized eyes. Early removal of AC-dislocated FAc implant is essential to prevent corneal edema and damage from raised intraocular pressure. AIM: To demonstrate a simple and novel technique, with a previous capsular tear, for removal of AC-migrated FAc implant and reinsertion into the vitreous cavity without compromising implant integrity. METHOD: A side port incision was created with a keratome and an anterior chamber maintainer introduced and secured. Subsequently, a corneal incision was created at 12 o’clock through which a 23-gauge backflush needle (flute needle) was advanced into the anterior chamber and passive suction used to secure the implant. The flute needle was then placed through the defect in the posterior capsule and the exit port blocked, causing loss of suction and allowing the implant to fall into the posterior segment. The sulcus intraocular lens (IOL) was centralized simply by manipulating it approximately 180 degrees to provide adequate anterior capsule support. RESULTS: The FAc implant was successfully removed from AC in two patients and reinserted into the vitreous cavity without damage or complications either for the eye or the implant. IOL in both patients were repositioned to close the gap in posterior capsule. After 2 months, the implant remains in the vitreous cavity. This paper presents data from one of these cases. CONCLUSION: Using 23-gauge flute needle to retrieve dislocated FAc implant is a safe and easy technique. FUNDING: Alimera Sciences Ltd. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40123-015-0035-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4675734
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-46757342015-12-18 A Novel Technique for Repositioning of a Migrated ILUVIEN(®) (Fluocinolone Acetonide) Implant into the Anterior Chamber El-Ghrably, Ibraheem A. Saad, Ahmed Dinah, Christiana Ophthalmol Ther Case Report INTRODUCTION: Fluocinolone acetonide (FAc) intravitreal implant (ILUVIEN(®); Alimera Sciences Limited, Aldershot, UK) has been approved in the UK for the treatment of chronic diabetic macula edema, insufficiently responsive to available therapies. It is inserted into the vitreous cavity through a 25-gauge needle. Migration of the implant to the anterior chamber (AC) can occur through gaps in the posterior capsule especially in vitrectomized eyes. Early removal of AC-dislocated FAc implant is essential to prevent corneal edema and damage from raised intraocular pressure. AIM: To demonstrate a simple and novel technique, with a previous capsular tear, for removal of AC-migrated FAc implant and reinsertion into the vitreous cavity without compromising implant integrity. METHOD: A side port incision was created with a keratome and an anterior chamber maintainer introduced and secured. Subsequently, a corneal incision was created at 12 o’clock through which a 23-gauge backflush needle (flute needle) was advanced into the anterior chamber and passive suction used to secure the implant. The flute needle was then placed through the defect in the posterior capsule and the exit port blocked, causing loss of suction and allowing the implant to fall into the posterior segment. The sulcus intraocular lens (IOL) was centralized simply by manipulating it approximately 180 degrees to provide adequate anterior capsule support. RESULTS: The FAc implant was successfully removed from AC in two patients and reinserted into the vitreous cavity without damage or complications either for the eye or the implant. IOL in both patients were repositioned to close the gap in posterior capsule. After 2 months, the implant remains in the vitreous cavity. This paper presents data from one of these cases. CONCLUSION: Using 23-gauge flute needle to retrieve dislocated FAc implant is a safe and easy technique. FUNDING: Alimera Sciences Ltd. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40123-015-0035-1) contains supplementary material, which is available to authorized users. Springer Healthcare 2015-07-22 2015-12 /pmc/articles/PMC4675734/ /pubmed/26199036 http://dx.doi.org/10.1007/s40123-015-0035-1 Text en © The Author(s) 2015 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Case Report
El-Ghrably, Ibraheem A.
Saad, Ahmed
Dinah, Christiana
A Novel Technique for Repositioning of a Migrated ILUVIEN(®) (Fluocinolone Acetonide) Implant into the Anterior Chamber
title A Novel Technique for Repositioning of a Migrated ILUVIEN(®) (Fluocinolone Acetonide) Implant into the Anterior Chamber
title_full A Novel Technique for Repositioning of a Migrated ILUVIEN(®) (Fluocinolone Acetonide) Implant into the Anterior Chamber
title_fullStr A Novel Technique for Repositioning of a Migrated ILUVIEN(®) (Fluocinolone Acetonide) Implant into the Anterior Chamber
title_full_unstemmed A Novel Technique for Repositioning of a Migrated ILUVIEN(®) (Fluocinolone Acetonide) Implant into the Anterior Chamber
title_short A Novel Technique for Repositioning of a Migrated ILUVIEN(®) (Fluocinolone Acetonide) Implant into the Anterior Chamber
title_sort novel technique for repositioning of a migrated iluvien(®) (fluocinolone acetonide) implant into the anterior chamber
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675734/
https://www.ncbi.nlm.nih.gov/pubmed/26199036
http://dx.doi.org/10.1007/s40123-015-0035-1
work_keys_str_mv AT elghrablyibraheema anoveltechniqueforrepositioningofamigratediluvienfluocinoloneacetonideimplantintotheanteriorchamber
AT saadahmed anoveltechniqueforrepositioningofamigratediluvienfluocinoloneacetonideimplantintotheanteriorchamber
AT dinahchristiana anoveltechniqueforrepositioningofamigratediluvienfluocinoloneacetonideimplantintotheanteriorchamber
AT elghrablyibraheema noveltechniqueforrepositioningofamigratediluvienfluocinoloneacetonideimplantintotheanteriorchamber
AT saadahmed noveltechniqueforrepositioningofamigratediluvienfluocinoloneacetonideimplantintotheanteriorchamber
AT dinahchristiana noveltechniqueforrepositioningofamigratediluvienfluocinoloneacetonideimplantintotheanteriorchamber